Medical Care Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2011
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '11 Dec 31, 2011
Revenue	1.07	0.66	0.73	3.47	-
Revenue Growth (YoY)	63.29%	-10.32%	-78.90%	-	-
Cost of Revenue	0.5	0.33	0.79	2.14	-
Gross Profit	0.58	0.32	-0.06	1.33	-
Selling, General & Admin	0.34	0.17	0.32	0.23	1.2
Operating Expenses	0.34	0.17	0.32	0.23	1.21
Operating Income	0.24	0.15	-0.38	1.1	-1.21
Interest Expense	-0.01	-0	-0.01	-	-0.49
Interest & Investment Income	0	-	-	-	-
Currency Exchange Gain (Loss)	-	-	-	-	0
Other Non Operating Income (Expenses)	0	-	-	-	-0.19
EBT Excluding Unusual Items	0.23	0.15	-0.39	1.1	-1.88
Other Unusual Items	-	-	-	-	-0.05
Pretax Income	0.23	0.15	-0.39	1.1	-1.93
Earnings From Continuing Operations	0.23	0.15	-0.39	1.1	-1.93
Minority Interest in Earnings	-	-	-	-	0.01
Net Income	0.23	0.15	-0.39	1.1	-1.92
Net Income to Common	0.23	0.15	-0.39	1.1	-1.92
Net Income Growth	53.46%	-	-	-	-
Shares Outstanding (Basic)	3,250	-	3,210	960	-
Shares Outstanding (Diluted)	3,250	-	3,210	960	-
Shares Change (YoY)	-	-	234.48%	-	-
EPS (Basic)	0.00	-	-0.00	0.00	-
EPS (Diluted)	0.00	-	-0.00	0.00	-
Free Cash Flow	0.1	-0.59	0.03	0.14	-0.38
Gross Margin	53.75%	49.03%	-7.82%	38.33%	-
Operating Margin	22.21%	23.31%	-52.05%	31.68%	-
Profit Margin	21.53%	22.91%	-52.94%	31.68%	-
Free Cash Flow Margin	9.12%	-89.51%	4.09%	4.02%	-
EBITDA	-	-	-	-	-1.2
D&A For EBITDA	-	-	-	-	0.01
EBIT	0.24	0.15	-0.38	1.1	-1.21
EBIT Margin	22.21%	23.31%	-52.05%	31.68%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.